Suppr超能文献

131I的甲状腺摄取:胶囊制剂与液体制剂的进一步比较

Thyroid uptake of 131I: further comparisons of capsules and liquid preparations.

作者信息

Green J P, Wilcox J R, Marriott J D, Halpern S E, Crews Q E

出版信息

J Nucl Med. 1976 Apr;17(4):310-2.

PMID:1255259
Abstract

Comparisons were made of thyroid uptake of three commercially available preparations of 131I, using a double-blind design, in 125 patients with normal thyroid function. Uptakes with Squibb Iodotope Diagnostic capsules were significantly lower than those with Squibb Iodotope Oral liquid at 4 hr (p less than 0.01) and 24 hr (p less than 0.05) after ingestion in both the general population and in all patients less than 45 years of age. Uptakes of Radiocaps I-131 (Abbott Laboratories) and Iodotope Oral liquid were indistinguishable under identical conditions. Our findings indicate that interference with either absorption or metabolism of a pharmaceutical can result from the vehicle used to administer it.

摘要

采用双盲设计,对125例甲状腺功能正常的患者使用三种市售的131I制剂进行甲状腺摄取比较。在普通人群以及所有年龄小于45岁的患者中,服用施贵宝碘同位素诊断胶囊后的摄取率在摄入后4小时(p<0.01)和24小时(p<0.05)显著低于施贵宝碘同位素口服液。在相同条件下,Radiocaps I-131(雅培实验室)和碘同位素口服液的摄取率没有差异。我们的研究结果表明,给药载体可能会干扰药物的吸收或代谢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验